Class of mental disorders where anxiety is the predominant feature.
Included in the DSM-5-TR, encompassing three main categories:
Phobic disorders
Panic disorder
Generalized Anxiety Disorder (GAD)
Definition: Characterized by marked, persistent, and excessive fear and avoidance of specific objects, activities, or situations.
Typically irrational but interfere with daily functioning.
Categories:
Animals
Natural environments
Situations (e.g., heights, public places)
Blood/injections/injury
Other (e.g., loud noises)
Social Phobia: Irrational fear of being publicly humiliated or embarrassed.
Definition: Sudden occurrence of multiple psychological and physiological symptoms that result in an overwhelming sense of terror.
Symptoms:
Shortness of breath
Heart palpitations
Sweating
Dizziness
Feelings of depersonalization
Some individuals mistake panic attacks for heart attacks.
Agoraphobia: The fear of public places, resulting in avoidance of situations where panic attacks might occur.
Definition: Chronic excessive worry that occurs alongside three or more of the following symptoms:
Restlessness
Fatigue
Concentration problems
Irritability
Muscle tension
Sleep disturbances
Strong genetic component present, leading to predispositions for developing anxiety disorders.
Key neurological areas involved:
Left hemisphere, temporal lobe abnormalities
Amygdala and related circuitry are implicated in anxiety disorders.
Classes of drugs:
Benzodiazepines:
Examples include : Diazepam (Valium), alprazolam (Xanax), lorazepam (Ativan).
Mechanism: Bind to GABA receptors, increasing hyperpolarization in postsynaptic cells, which reduces neuronal excitability.
Beneficial for preventing seizures and treating insomnia.
Other medications include SSRIs and SNRIs.
Definition: Characterized by chronic physiological arousal, recurrent intrusive thoughts or images of a traumatic event, and avoidance of triggers related to the trauma.
Often precipitated by stressful situations or reminders of trauma, with soldiers being a common demographic affected.
Approximately 7% of Americans are estimated to experience PTSD at some point.
Evidence for a heritable component to PTSD; incidence rates are higher in monozygotic twins compared to dizygotic twins.
Neurological changes associated with PTSD:
Role of the hippocampus:
Right hippocampus tends to be smaller in individuals with PTSD, which may predispose them to the disorder under stress.
Symptoms may include amnesia, flashbacks, and deficits in short-term memory (STM).
Cognitive Behavioral Therapy (CBT): effective in treating PTSD by gradually exposing individuals to triggering stimuli. Possible integration of virtual reality exposure therapy.
Combination with medications that block stress hormones, or unique therapies involving MDMA (Ecstasy).
Definition: Characterized by repetitive, intrusive thoughts (obsessions) and ritualistic behaviors (compulsions) aimed at reducing anxiety caused by those thoughts.
Symptoms often manifest in childhood but typically peak at ages 25-44.
Obsessions: Intrusive thoughts causing anxiety.
Compulsions: Behaviors performed to alleviate this anxiety.
Individuals with OCD have structural and functional changes in areas including:
Prefrontal cortex
Cingulate cortex
Basal ganglia
Insula
There is a genetic component involved, particularly associated with genes that influence serotonin signaling. Infections may also trigger symptoms.
Cognitive Behavioral Therapy (CBT): standard treatment method.
Medications that inhibit the reuptake of serotonin:
Examples include Fluoxetine (Prozac) and Fluvoxamine (Luvox).
OCD is often comorbid with depression, which complicates treatment as both disorders may be treated with similar medications targeting different regions of the prefrontal cortex (PFC).